Literature DB >> 16923799

Evidence for a colorectal cancer susceptibility locus on chromosome 3q21-q24 from a high-density SNP genome-wide linkage scan.

Zoe Kemp1, Luis Carvajal-Carmona, Sarah Spain, Ella Barclay, Margaret Gorman, Lynn Martin, Emma Jaeger, Neil Brooks, D Timothy Bishop, Huw Thomas, Ian Tomlinson, Elli Papaemmanuil, Emily Webb, Gabrielle S Sellick, Wendy Wood, Gareth Evans, Anneke Lucassen, Eamonn R Maher, Richard S Houlston.   

Abstract

To identify a novel susceptibility gene for colorectal cancer (CRC), we conducted a genome-wide linkage analysis of 69 pedigrees segregating colorectal neoplasia in which involvement of known loci had been excluded, using a high-density single nucleotide polymorphism (SNP) array containing 10,204 markers. Multipoint linkage analyses were undertaken using both non-parametric (model-free) and parametric (model-based) methods. After the removal of SNPs in strong linkage disequilibrium, we obtained a maximum non-parametric linkage statistic of 3.40 (P=0.0003) at chromosomal region 3q21-q24. The same genomic position also yielded the highest multipoint heterogeneity LOD (HLOD) score under a dominant model (HLOD=3.10, genome-wide P=0.038) with 62% of families linked to the locus. We provide evidence for a novel CRC susceptibility gene. Further studies are needed to confirm this localization and to evaluate the contribution of this locus to disease incidence.

Entities:  

Mesh:

Year:  2006        PMID: 16923799     DOI: 10.1093/hmg/ddl231

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  34 in total

1.  Colorectal adenomas and cancer link to chromosome 13q22.1-13q31.3 in a large family with excess colorectal cancer.

Authors:  Deborah W Neklason; Thérèse M Tuohy; Jeffery Stevens; Brith Otterud; Lisa Baird; Richard A Kerber; Wade S Samowitz; Scott K Kuwada; Mark F Leppert; Randall W Burt
Journal:  J Med Genet       Date:  2010-06-03       Impact factor: 6.318

2.  Characterization of a 3;6 translocation associated with renal cell carcinoma.

Authors:  Rebecca E Foster; Mahera Abdulrahman; Mark R Morris; Elena Prigmore; Susan Gribble; Beeling Ng; Dean Gentle; Steven Ready; Phil M T Weston; Michael S Wiesener; Takeshi Kishida; Masahiro Yao; Val Davison; Jose Luis Barbero; Carol Chu; Nigel P Carter; Farida Latif; Eamonn R Maher
Journal:  Genes Chromosomes Cancer       Date:  2007-04       Impact factor: 5.006

3.  Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation.

Authors:  Derville O'Shea; Ciarán O'Riain; Manu Gupta; Rachel Waters; Youwen Yang; David Wrench; John Gribben; Andreas Rosenwald; German Ott; Lisa M Rimsza; Harald Holte; Jean-Baptiste Cazier; Nathalie A Johnson; Elias Campo; Wing C Chan; Randy D Gascoyne; Bryan D Young; Louis M Staudt; T Andrew Lister; Jude Fitzgibbon
Journal:  Blood       Date:  2009-01-13       Impact factor: 22.113

4.  Long Noncoding RNAs in Colorectal Adenocarcinoma; an in silico Analysis.

Authors:  Hossein Ansari; Arman Shahrisa; Yaser Tahmasebi Birgani; Maryam Tahmasebi Birgani; Mohammadreza Hajjari; Javad Mohammadi Asl
Journal:  Pathol Oncol Res       Date:  2018-06-13       Impact factor: 3.201

Review 5.  Hereditary and familial colon cancer.

Authors:  Kory W Jasperson; Thérèse M Tuohy; Deborah W Neklason; Randall W Burt
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

6.  Evidence of linkage to chromosomes 10p15.3-p15.1, 14q24.3-q31.1 and 9q33.3-q34.3 in non-syndromic colorectal cancer families.

Authors:  Ian W Saunders; Jason Ross; Finlay Macrae; Graeme P Young; Ignacio Blanco; Jesper Brohede; Glenn Brown; Diana Brookes; Trevor Lockett; Peter L Molloy; Victor Moreno; Gabriel Capella; Garry N Hannan
Journal:  Eur J Hum Genet       Date:  2011-08-10       Impact factor: 4.246

7.  Association of a let-7 miRNA binding region of TGFBR1 with hereditary mismatch repair proficient colorectal cancer (MSS HNPCC).

Authors:  Rosa M Xicola; Sneha Bontu; Brian J Doyle; Jamie Rawson; Pilar Garre; Esther Lee; Miguel de la Hoya; Xavier Bessa; Joan Clofent; Luis Bujanda; Francesc Balaguer; Sergi Castellví-Bel; Cristina Alenda; Rodrigo Jover; Clara Ruiz-Ponte; Sapna Syngal; Montserrat Andreu; Angel Carracedo; Antoni Castells; Polly A Newcomb; Noralane Lindor; John D Potter; John A Baron; Nathan A Ellis; Trinidad Caldes; Xavier LLor
Journal:  Carcinogenesis       Date:  2016-05-27       Impact factor: 4.944

8.  Genome-wide linkage analysis and tumoral characterization reveal heterogeneity in familial colorectal cancer type X.

Authors:  E Sánchez-Tomé; B Rivera; J Perea; G Pita; D Rueda; F Mercadillo; A Canal; A Gonzalez-Neira; J Benitez; M Urioste
Journal:  J Gastroenterol       Date:  2014-11-09       Impact factor: 7.527

Review 9.  New genes emerging for colorectal cancer predisposition.

Authors:  Clara Esteban-Jurado; Pilar Garre; Maria Vila; Juan José Lozano; Anna Pristoupilova; Sergi Beltrán; Anna Abulí; Jenifer Muñoz; Francesc Balaguer; Teresa Ocaña; Antoni Castells; Josep M Piqué; Angel Carracedo; Clara Ruiz-Ponte; Xavier Bessa; Montserrat Andreu; Luis Bujanda; Trinidad Caldés; Sergi Castellví-Bel
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

10.  COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer.

Authors:  I P M Tomlinson; M Dunlop; H Campbell; B Zanke; S Gallinger; T Hudson; T Koessler; P D Pharoah; I Niittymäki; I Niittymäkix; S Tuupanen; S Tuupanenx; L A Aaltonen; K Hemminki; A Lindblom; A Försti; O Sieber; L Lipton; T van Wezel; H Morreau; J T Wijnen; P Devilee; K Matsuda; Y Nakamura; S Castellví-Bel; C Ruiz-Ponte; A Castells; A Carracedo; J W C Ho; P Sham; R M W Hofstra; P Vodicka; H Brenner; J Hampe; C Schafmayer; J Tepel; S Schreiber; H Völzke; M M Lerch; C A Schmidt; S Buch; V Moreno; C M Villanueva; P Peterlongo; P Radice; M M Echeverry; A Velez; L Carvajal-Carmona; R Scott; S Penegar; P Broderick; A Tenesa; R S Houlston
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.